Matthew Reynolds

Matthew Reynolds is a Professor at UMass Chan Medical School, affiliated with the Department of Medicine at UMass Chan - Lahey and based at Lahey Hospital and Medical Center. His academic background includes a BS in Biology & Society/Psychology from Cornell University, an MS in Health Policy & Management from Harvard University, and a medical degree (DOCM) from the University of Pennsylvania. His research spans cardiology, electrophysiology, stroke prevention, and health policy, with a focus on atrial fibrillation management, catheter ablation outcomes, and cost-effectiveness in cardiovascular care.

Dr. Reynolds' work frequently addresses clinical innovations such as cardiac monitoring devices, transcatheter therapies, and stroke prevention strategies. His publications emphasize real-world outcomes, economic evaluations, and patient-centered metrics in cardiovascular interventions. Key research themes include atrial fibrillation ablation efficacy, left atrial appendage closure, and SGLT2 inhibitors in comorbid populations.

His articles predominantly explore electrophysiology techniques, healthcare utilization patterns, and therapeutic innovations. Recent studies highlight trends in minimally invasive cardiac procedures, long-term device outcomes, and socioeconomic factors influencing arrhythmia management. Awards and grants are not detailed in the source text.